Characterization of Skin Changes (Clinical, Physiological, and Pathological) From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse Events

Part of paid clinical trials in Palo Alto, California.

Sponsor
Stanford University
Study ID
NCT07767448
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • La Roche Posay Lipikar Wash Atopy-Prone Plus (AP+) Moisturizing Face and Body Wash — OTHER
    Moisturizer wash applied once in the morning and once in the evening.
  • La Roche Posay Lipikar AP+ Triple Repair Moisturizing Cream — OTHER
    Moisturizer applied once in the morning and once in the evening.
  • La Roche Posay Cicaplast balm Panthenol/Vitamin B5 (B5+) — OTHER
    Balm applied once in the morning and once in the evening.

Study Details

The goal of this clinical trial is to evaluate whether cosmeceutical topical moisturizers can help with skin dryness in participants with cancer experiencing a dermatological adverse event from cancer therapies. The main question it aims to answer is: Does cosmeceutical topical moisturizers help with skin dryness? Participants will: * Visit the clinic for a baseline visit to complete skin evaluation and tests. * Apply cosmeceutical topical moisturizers daily from baseline up until the follow-up visit. * Visit the clinic for a follow-up visit (approximately 2-4 weeks from baseline) for a repeat skin evaluation and tests.

Key Dates

First listed
Aug 17, 2026
Start date
Aug 31, 2026
Status verified
Aug 2026
Primary completion
Sep 30, 2028
Completion
Feb 28, 2029

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Moisturizer
    Participants in this arm will apply the following cosmeceutical topical moisturizers twice daily (once in the morning and once in the evening) for the duration of the study: 1. La Roche Posay Lipikar wash Atopy-Prone Plus (AP+) moisturizing face and body wash (once in the morning and once in the evening) 2. La Roche Posay Lipikar AP+ triple repair moisturizing cream (once in the morning and once in the evening) 3. La Roche Posay Cicaplast balm Panthenol/Vitamin B5 (B5+) (once in the morning and once in the evening)

Primary Outcome Measure

Change in Patient-Reported Skin Dryness Severity [ Time Frame: From baseline visit to follow-up visit (approximately 2-4 weeks). ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford Health Care: Supportive Dermato-Oncology ProgramPalo AltoCalifornia94304
Hannah Clinical Research Coordinator
[email protected]
650-487-1218
Lisa Zaba, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Palo Alto, CA

By research site
Stanford Health Care: Supportive Dermato-Oncology Program· Palo Alto, CA

Related Studies